The EU Court of Justice renders a preliminary ruling stating that a dispute between an originator and a generics manufacturer constitutes evidence that they are potential competitors (Generics - UK / GlaxoSmithKline / Actavis / Xellia Pharmaceuticals / Merck / Alpharma)

Drakakakis, Stamatis; Papaefthymiou, Argyris; Gavriilidou, Ellie

Previous article The EU Court of Justice clarifies the conditions under which pay-for-delay agreements preventing generic versions of a patented medicine from entering the market or delaying such entry may constitute a restriction of competition "by object" or "by effect" as well as an abuse of dominant position (Generics - UK / GlaxoSmithKline / Actavis / Xellia Pharmaceuticals / Merck / Alpharma) Next article The EU Commission imposes fines totally €14M on several companies including a film and TV production company for restricting sales of film merchandise products (NBCUniversal)

30 Jan 2020

The EU Court of Justice renders a preliminary ruling stating that a dispute between an originator and a generics manufacturer constitutes evidence that they are potential competitors (Generics - UK / GlaxoSmithKline / Actavis / Xellia Pharmaceuticals / Merck / Alpharma)

KEYWORDS

Reference

EU Court of Justice, Generics - UK / GlaxoSmithKline / Actavis / Xellia Pharmaceuticals / Merck / Alpharma, Case No. C-307/18, Judgement, 30 January 2020

On 30 January 2020, the Court of Justice of the EU rendered its preliminary ruling in Case C-307/18 – Generics (UK) and Others v CMA (Paroxetine). The case originated in a preliminary reference made by the UK Competition Appeal Tribunal (CAT) relating to an

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

PDF Version

Authors

Stamatis Drakakakis
Zepos & Yannopoulos (Athens)

Greece 35 contributions 3441 visits
Argyris Papaefthymiou
Athens Bar Association

United Kingdom 34 contributions 2961 visits
Ellie Gavriilidou
Zepos & Yannopoulos (Athens)

Greece 29 contributions 2338 visits

Quotation

Stamatis Drakakakis, Argyris Papaefthymiou, Ellie Gavriilidou, The EU Court of Justice renders a preliminary ruling stating that a dispute between an originator and a generics manufacturer constitutes evidence that they are potential competitors (Generics - UK / GlaxoSmithKline / Actavis / Xellia Pharmaceuticals / Merck / Alpharma), 30 January 2020, e-Competitions January 2020, Art. N° 100061

Visites 112